{"id":"W2615856394","doi":"10.1200/jco.2012.30.15_suppl.4500","title":"Cardiac safety analysis for a phase III trial of sunitinib (SU) or sorafenib (SO) or placebo (PLC) in patients (pts) with resected renal cell carcinoma (RCC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Ejection fraction; Sunitinib; Heart failure; Clinical endpoint; Internal medicine; Cardiology; Renal cell carcinoma; Placebo; Myocardial infarction; Population; Sorafenib; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002573181,0.000654584,0.001042102,0.0002801121,0.0002403844,0.0007070909,0.0004147823,0.0006644289,0.003569584],"category_scores_gemma":[0.001558372,0.0002737846,0.001394108,0.0003287494,0.0004498818,0.0004180022,0.0002823804,0.001228464,0.0004536566],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006002866,"about_ca_system_score_gemma":0.00113874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003463239,"about_ca_topic_score_gemma":0.00105524,"domain_scores_codex":[0.9991063,0.0005990237,0.00004356737,0.0001074697,0.00007187074,0.00007171983],"domain_scores_gemma":[0.9990306,0.0002099734,0.0003097635,0.00006875284,0.0000581701,0.0003227947],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.916318,0.005992376,0.01692952,0.0006575661,0.00232757,0.0002082702,0.0001102342,0.001488706,0.0128587,0.0002690569,0.0029562,0.03988387],"study_design_scores_gemma":[0.6647317,0.254467,0.06689453,0.00007323325,0.002382234,0.0005381377,0.00007348819,0.002472858,0.002649067,0.0004939652,0.005188733,0.00003501627],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898605,0.002079727,0.001016494,0.0004057304,0.00008617181,0.002009392,0.002294868,0.00007808366,0.002169246],"genre_scores_gemma":[0.9929027,0.0006732047,0.0008730358,0.0005159529,0.0001086547,0.001443094,0.002528128,0.00001389585,0.0009412853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003569584,"threshold_uncertainty_score":0.0136084,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1357241711022873,"score_gpt":0.4367950224942761,"score_spread":0.3010708513919888,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}